|
US4916135A
(en)
|
1989-05-08 |
1990-04-10 |
Hoechst Roussel Pharmaceuticals Inc. |
N-heteroaryl-4-quinolinamines
|
|
US5710158A
(en)
|
1991-05-10 |
1998-01-20 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
AU661533B2
(en)
|
1992-01-20 |
1995-07-27 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
JP2994165B2
(ja)
*
|
1992-06-26 |
1999-12-27 |
ゼネカ・リミテッド |
キナゾリン誘導体、その製造法および該キナゾリン誘導体を含有する抗癌作用を得るための医薬調剤
|
|
GB9510757D0
(en)
|
1994-09-19 |
1995-07-19 |
Wellcome Found |
Therapeuticaly active compounds
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
US6046206A
(en)
|
1995-06-07 |
2000-04-04 |
Cell Pathways, Inc. |
Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
|
|
ATE227283T1
(de)
|
1996-07-13 |
2002-11-15 |
Glaxo Group Ltd |
Kondensierte heterozyklische verbindungen als protein kinase inhibitoren
|
|
WO1998005647A1
(en)
|
1996-08-01 |
1998-02-12 |
Dow Agrosciences Llc |
Quinolinium derivatives having fungicidal activity
|
|
AU733551B2
(en)
|
1996-09-25 |
2001-05-17 |
Astrazeneca Ab |
Qinoline derivatives inhibiting the effect of growth factors such as VEGF
|
|
UA73073C2
(uk)
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
PT1117653E
(pt)
|
1998-10-01 |
2003-06-30 |
Astrazeneca Ab |
Derivados de quinolina e quinazolina e sua utilizacao como inibidores de doencas mediadas pela citosina
|
|
GB2345486A
(en)
|
1999-01-11 |
2000-07-12 |
Glaxo Group Ltd |
Heteroaromatic protein tyrosine kinase inhibitors
|
|
RU2002110461A
(ru)
|
1999-09-21 |
2004-03-10 |
Астразенека Аб (Se) |
Производные хиназолина и их применение в качестве фармацевтических веществ
|
|
EP1294709A2
(en)
|
2000-01-28 |
2003-03-26 |
AstraZeneca AB |
Quinoline derivatives and their use as aurora 2 kinase inhibitors
|
|
CN1429222A
(zh)
|
2000-02-17 |
2003-07-09 |
安姆根有限公司 |
激酶抑制剂
|
|
US6521618B2
(en)
|
2000-03-28 |
2003-02-18 |
Wyeth |
3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
|
|
US6589758B1
(en)
|
2000-05-19 |
2003-07-08 |
Amgen Inc. |
Crystal of a kinase-ligand complex and methods of use
|
|
NZ523358A
(en)
|
2000-08-09 |
2004-09-24 |
Astrazeneca Ab |
Quinoline derivatives having VEGF inhibiting activity
|
|
GB0025782D0
(en)
|
2000-10-20 |
2000-12-06 |
Pfizer Ltd |
Use of inhibitors
|
|
US6548508B2
(en)
|
2000-10-20 |
2003-04-15 |
Pfizer, Inc. |
Use of PDE V inhibitors for improved fecundity in mammals
|
|
GB0104422D0
(en)
|
2001-02-22 |
2001-04-11 |
Glaxo Group Ltd |
Quinoline derivative
|
|
HN2002000067A
(es)
|
2001-03-23 |
2003-10-24 |
Bayer Healthcare Llc |
Inhibidores de la rho - quinasa.
|
|
WO2002076977A2
(en)
|
2001-03-23 |
2002-10-03 |
Bayer Corporation |
Rho-kinase inhibitors
|
|
SE0101675D0
(sv)
|
2001-05-11 |
2001-05-11 |
Astrazeneca Ab |
Novel composition
|
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
|
WO2003026666A1
(en)
|
2001-09-26 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
2-phenylamino-4- (5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, as src kinase inhibitors
|
|
US7402585B2
(en)
|
2001-12-24 |
2008-07-22 |
Astrazeneca Ab |
Substituted quinazoline derivatives as inhibitors of aurora kinases
|
|
US7645878B2
(en)
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
|
TWI275390B
(en)
|
2002-04-30 |
2007-03-11 |
Wyeth Corp |
Process for the preparation of 7-substituted-3- quinolinecarbonitriles
|
|
AU2003255482A1
(en)
*
|
2002-10-02 |
2004-04-23 |
Merck Patent Gmbh |
Use of 4 amino-quinazolines as anti cancer agents
|
|
WO2004037814A1
(en)
|
2002-10-25 |
2004-05-06 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
|
US20040122161A1
(en)
|
2002-12-21 |
2004-06-24 |
Paul Charles W. |
Hot melt adhesive based on acrylic block copolymers
|
|
NZ540698A
(en)
|
2002-12-24 |
2008-05-30 |
Astrazeneca Ab |
Phosphonooxy quinazoline derivatives and their pharmaceutical use
|
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
|
MXPA05012839A
(es)
|
2003-05-27 |
2006-05-17 |
Pfizer Prod Inc |
Quinazolinas y pirido[3,4-d] pirimidinas como inhibidores de receptores tirosina quinasa.
|
|
CN1984660B
(zh)
|
2003-07-03 |
2010-12-15 |
美瑞德生物工程公司 |
作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉
|
|
PL1667991T3
(pl)
|
2003-09-16 |
2008-12-31 |
Astrazeneca Ab |
Pochodne chinazoliny jako inhibitory kinazy tyrozynowej
|
|
EP2210607B1
(en)
|
2003-09-26 |
2011-08-17 |
Exelixis Inc. |
N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer
|
|
BRPI0418102A
(pt)
|
2003-12-23 |
2007-04-27 |
Pfizer |
derivados de quinolina
|
|
CN1934100A
(zh)
|
2004-03-23 |
2007-03-21 |
万有制药株式会社 |
取代喹唑啉或吡啶并嘧啶衍生物
|
|
WO2005115145A2
(en)
|
2004-05-20 |
2005-12-08 |
Wyeth |
Quinone substituted quinazoline and quinoline kinase inhibitors
|
|
EP2295054A1
(en)
|
2004-05-27 |
2011-03-16 |
Vertex Pharmaceuticals Incorporated |
Ice inhibitors for the treatment of autoinflammatory diseases
|
|
CA2569404A1
(en)
|
2004-06-04 |
2005-12-22 |
Amphora Discovery Corporation |
Quinoline- and isoquinoline-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
|
FR2873695A1
(fr)
|
2004-07-30 |
2006-02-03 |
Palumed Sa |
Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien
|
|
CA2592009A1
(en)
|
2004-12-22 |
2006-06-29 |
Bayer Schering Pharma Aktiengesellschaft |
Quinoline derivative, its use, production and pharmaceutical agents containing the latter
|
|
US8258145B2
(en)
|
2005-01-03 |
2012-09-04 |
Myrexis, Inc. |
Method of treating brain cancer
|
|
US20080161305A1
(en)
|
2005-04-06 |
2008-07-03 |
Exelixis, Inc. |
C-Met Modulators and Methods of Use
|
|
JO2787B1
(en)
|
2005-04-27 |
2014-03-15 |
امجين إنك, |
Alternative amide derivatives and methods of use
|
|
EP1746096A1
(en)
|
2005-07-15 |
2007-01-24 |
4Sc Ag |
2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer
|
|
ITMI20052008A1
(it)
|
2005-10-21 |
2007-04-22 |
Ctg Pharma S R L |
Nuovi antimalarici derivati della 4-aminochinolina
|
|
FR2902100A1
(fr)
|
2006-06-13 |
2007-12-14 |
Sanofi Aventis Sa |
Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique
|
|
US7511063B2
(en)
|
2006-08-16 |
2009-03-31 |
Schering Corporation |
High affinity quinoline-based kinase ligands
|
|
JP2008063278A
(ja)
|
2006-09-07 |
2008-03-21 |
Fujifilm Finechemicals Co Ltd |
１−ピリジン−４−イル−インドール類の製造方法
|
|
BRPI0715016A2
(pt)
|
2006-09-11 |
2013-05-28 |
Curis Inc |
composiÇço, composiÇço farmacÊutica, mÉtodo para tratar uma doenÇa ou distérbio relacionada com tirosina quinase de egfr em um individuo necessitando o mesmo, mÉtodo para tratar uma doenÇa mediada por hdac e mÉtodo para tratar doenÇas medidas tanto por tirosina quinase de egfr quanto hdac
|
|
KR20090077914A
(ko)
|
2006-09-11 |
2009-07-16 |
쿠리스 인코퍼레이션 |
항증식제로서의 다작용성 소분자
|
|
EP2061469B8
(en)
|
2006-09-11 |
2014-02-26 |
Curis, Inc. |
Quinazoline based egfr inhibitors
|
|
TW200829555A
(en)
|
2006-11-10 |
2008-07-16 |
Astrazeneca Ab |
Chemical compounds
|
|
US8148532B2
(en)
|
2007-03-14 |
2012-04-03 |
Guoqing Paul Chen |
Spiro substituted compounds as angiogenesis inhibitors
|
|
US8163923B2
(en)
|
2007-03-14 |
2012-04-24 |
Advenchen Laboratories, Llc |
Spiro substituted compounds as angiogenesis inhibitors
|
|
US20080234267A1
(en)
|
2007-03-20 |
2008-09-25 |
Karen Elizabeth Lackey |
Compounds and Methods of Treatment
|
|
WO2008119771A2
(en)
|
2007-03-30 |
2008-10-09 |
Clanotech Ab |
Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors
|
|
CA2684644A1
(en)
|
2007-04-23 |
2008-10-30 |
Sanofi-Aventis |
Quinoline-carboxamide derivatives as p2y12 antagonists
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
CA2964162C
(en)
|
2007-06-01 |
2019-12-31 |
Wyeth Llc |
Treatment of imatinib resistant leukemia using 4-aminoquinoline-3-carbonitriles having mutation in the bcrabl gene
|
|
CN101362719B
(zh)
|
2007-08-06 |
2012-04-18 |
北京师范大学 |
喹啉类衍生物以及包含其的组合物
|
|
US7939546B2
(en)
|
2007-10-12 |
2011-05-10 |
Supergen, Inc. |
Quinoline derivatives for modulating DNA methylation
|
|
US7790746B2
(en)
|
2007-10-12 |
2010-09-07 |
Supergen, Inc. |
Quinoline derivatives for modulating DNA methylation
|
|
WO2009073746A1
(en)
|
2007-12-07 |
2009-06-11 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Apparatus for countercurrent chromatography
|
|
EP2072502A1
(de)
*
|
2007-12-20 |
2009-06-24 |
Bayer Schering Pharma Aktiengesellschaft |
Sulfoximid-substituierte Chinolin- und Chinazolinderivate als Kinase-Inhibitoren
|
|
GB0801416D0
(en)
|
2008-01-25 |
2008-03-05 |
Piramed Ltd |
Pharmaceutical compounds
|
|
BRPI0906099A2
(pt)
|
2008-03-06 |
2015-07-21 |
Genentech Inc |
"método de tratamento do câncer em um indivíduo"
|
|
CA2739302A1
(en)
*
|
2008-10-17 |
2010-04-22 |
Brendan C. Bender |
Treatment method
|
|
DE102008062566A1
(de)
|
2008-12-16 |
2010-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Aminosäureester-Prodrugs und ihre Verwendung
|
|
PH12012500097A1
(en)
|
2009-07-21 |
2011-01-27 |
Shanghai Inst Organic Chem |
Potent small molecule inhibitors of autophagy, and methods of use thereof
|
|
WO2011112588A2
(en)
|
2010-03-08 |
2011-09-15 |
Case Western Reserve University |
Compositions and methods for treating inflammatory disorders
|
|
WO2011120026A1
(en)
|
2010-03-26 |
2011-09-29 |
Glaxo Group Limited |
Pyrazolyl-pyrimidines as kinase inhibitors
|
|
WO2011120025A1
(en)
|
2010-03-26 |
2011-09-29 |
Glaxo Group Limited |
Indazolyl-pyrimidines as kinase inhibitors
|
|
WO2011123609A1
(en)
|
2010-03-31 |
2011-10-06 |
Glaxo Group Limited |
Imidazolyl-imidazoles as kinase inhibitors
|
|
JP2013526484A
(ja)
|
2010-05-07 |
2013-06-24 |
グラクソ グループ リミテッド |
キナーゼ阻害剤としてのアミノ‐キノリン
|
|
UY33549A
(es)
|
2010-08-10 |
2012-01-31 |
Glaxo Group Ltd |
Quinolil aminas como agentes inhibidores de las quinasas
|
|
US8609672B2
(en)
|
2010-08-27 |
2013-12-17 |
University Of The Pacific |
Piperazinylpyrimidine analogues as protein kinase inhibitors
|
|
US9133162B2
(en)
|
2011-02-28 |
2015-09-15 |
Sunshine Lake Pharma Co., Ltd. |
Substituted quinoline compounds and methods of use
|
|
ES2609578T3
(es)
|
2011-03-04 |
2017-04-21 |
Glaxosmithkline Intellectual Property Development Limited |
Amino-quinolinas como inhibidores de quinasa
|
|
TWI547494B
(zh)
*
|
2011-08-18 |
2016-09-01 |
葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之胺基喹唑啉類
|
|
AR092530A1
(es)
|
2012-09-13 |
2015-04-22 |
Glaxosmithkline Llc |
Compuesto de amino-quinolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento
|
|
AR092529A1
(es)
|
2012-09-13 |
2015-04-22 |
Glaxosmithkline Llc |
Compuesto de aminoquinazolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento
|
|
TWI630203B
(zh)
|
2013-02-21 |
2018-07-21 |
葛蘭素史克智慧財產發展有限公司 |
做為激酶抑制劑的喹唑啉類
|